002019 亿帆医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.4694.596-6.4502.2053.280
总资产报酬率 ROA (%)3.0543.245-4.5841.5482.339
投入资产回报率 ROIC (%)3.4423.595-5.0541.7072.591

边际利润分析
销售毛利率 (%)47.82047.42047.84048.63541.469
营业利润率 (%)11.1077.400-21.6983.7484.813
息税前利润/营业总收入 (%)11.9618.961-19.9164.6656.419
净利润/营业总收入 (%)9.1846.272-21.7713.3125.494

收益指标分析
经营活动净收益/利润总额(%)95.586103.341-3.012118.914106.878
价值变动净收益/利润总额(%)-5.284-3.6441.733-11.250-2.130
营业外收支净额/利润总额(%)-0.2061.762-1.5748.249-0.668

偿债能力分析
流动比率 (X)1.2681.2651.4861.6781.558
速动比率 (X)0.8740.9111.0621.3001.269
资产负债率 (%)33.55531.41028.21627.08327.871
带息债务/全部投入资本 (%)21.26220.35118.59319.21419.673
股东权益/带息债务 (%)360.341380.457425.239404.494391.875
股东权益/负债合计 (%)200.809220.831255.052259.376251.733
利息保障倍数 (X)13.6496.274-13.7728.0483.919

营运能力分析
应收账款周转天数 (天)102.96086.279101.414105.96885.022
存货周转天数 (天)158.106131.654149.262136.53687.028